5 / 16
Infectious Diseases
and STD-AIDS
Infectious Diseases and STD-AIDS 2018
Journal of Transmitted Diseases and Immunity
ISSN 2471-8084
A p r i l 2 6 - 2 7 , 2 0 1 8
R o m e , I t a l y
Page 25
W
e, were so preoccupied with whether, or not we could, we did not stop,
to think if we should. It's ironic, a fantasy movie. Aptly, describes the
medical crisis we face today, I am talking about emerging and antibiotic-
resistant bacterial infections and how to prevent them spread resulting in
epidemics and pandemics that can kill 10 million people per year by 2050.
We are now facing a mortal enemy that surpasses our own Intelligence. A tiny
microorganism that has indeed, brought us to our knees. It has learned from us,
adapted to us, and now exploits our genetic vulnerability, with lethal precision.
Pharmaceuticals, medical devicemanufacturers, government and doctors have
now started accepted and acknowledging this as a major crisis of 21st Century.
Unfortunately, they are offering incentives and financial support to projects
and research that may never bring in the miracle cure and save millions of lives
as it did in the past. By not guarding the miracle drug as custodians, we allowed
antibiotics to, fatten chickens, treat animals, encouraging nurses to use our
clinical skill to diagnose illness, prescribe drugs, and chemist to sell antibiotics
without the prescription. We have now lost the only drug that helped us fight
infections, learn more about our body, make advances in medicine possible,
perform surgical procedures, transplant surgery, IVF and, Save millions of
people. My mission is to help encourage, members of our profession to, share
knowledge, Innovate and develop products, and method to fight infection. My
message to members of my profession is to reduce wasted consultations, cost
of healthcare, antibiotic abuse and cross infections and help us this war with
bugs that we cannot see. I hope to discourage people in power, institutions and
pharmaceuticals companies stop this dream of inventing a miracle cure, tests,
investigations and talking about boosting immunity knowing the bugs are
smarter, stronger and well adapted to survive and think of alternate strategy of
integrating innovations to initially identify infected individuals and isolate them
to protect humanity.
Biography
Author, doctor, inventor and publisher who worked in acute as
staff and associate specialist in acute and intensive paediatric
care in internationally respected hospitals in the UK. Special in-
terest “Spreading Superbugs & Emerging Infections”. In 2000,
he was appointed to teach nurses to manage infection in pilot
nurse-led practice. He raised concern in 2004, about wrong do-
ings and antibiotic abuse and the quality of care offered using
protocols by nurse prescribers and practitioners. To protect
fellow human for un-ethical medical practice, he collected and
compiled a list of common symptoms and developed a simple
tool “Maya” to help patients differentiate “Well from Non-Well”.
His created “Dr Maya” using Internet and communication tech-
nology to reduce the cultural dependency, cost, medical errors,
delay in diagnosis, treatment and antibiotic abuse. His mission
is to reduce cross infections with treatment resistant infections
by helping doctors initially identify infected individual and isolate
them to protect healthcare workers and pandemics.
medifix@gmail.comELEPHANT IN THE DOCTORS ROOM”: Emerging And Antibiotic Resistant
Microorganisms That Threaten Healthcare Workers
Kadiyali M. Srivatsa
NHS & Private Healthcare, UK
Kadiyali M. Srivatsa, J Transm Dis Immun 2018 Volume 2
DOI: 10.21767/2573-0320-C1-002